Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Open-lable, Multicenter, Phase II Clinical Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer

NCT04740021 is registered in ClinicalTrials.gov with Taizhou HoudeAoke Biomedical Co., Ltd. as lead sponsor.

NCT NCT04740021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04740021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Open-lable, Multicenter, Phase II Clinical Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer
Lead sponsor
Taizhou HoudeAoke Biomedical Co., Ltd.
Phase
Phase 2
Overall status
Unknown status
Start date
December 2, 2020
Completion date
August 1, 2022
Enrollment
46 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

small-cell lung cancer